SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-026719
Filing Date
2022-11-10
Accepted
2022-11-10 07:15:37
Documents
63
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q arav20220930_10q.htm   iXBRL 10-Q 1050383
2 EXHIBIT 31.1 ex_417751.htm EX-31.1 12058
3 EXHIBIT 31.2 ex_417752.htm EX-31.2 12082
4 EXHIBIT 32.1 ex_417753.htm EX-32.1 5441
5 EXHIBIT 32.2 ex_417754.htm EX-32.2 5465
  Complete submission text file 0001437749-22-026719.txt   5170896

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA arav-20220930.xsd EX-101.SCH 48718
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arav-20220930_cal.xml EX-101.CAL 28080
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arav-20220930_def.xml EX-101.DEF 338966
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE arav-20220930_lab.xml EX-101.LAB 294860
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arav-20220930_pre.xml EX-101.PRE 363097
57 EXTRACTED XBRL INSTANCE DOCUMENT arav20220930_10q_htm.xml XML 746453
Mailing Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098
Business Address RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 936-355-1910
Aravive, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 221374920
SIC: 2834 Pharmaceutical Preparations